Rethink Imaging
What 5.2 Million CT Scans Taught Us About Patient Radiation Dose | Tom Griglock & Kalpana Kanal
September 18, 2026
In this episode of Rethink Imaging, host Chris St. John sits down with Dr. Kalpana Kanal and Dr. Thomas Griglock to discuss the newly updated Diagnostic Reference Levels (DRLs) and Achievable Doses (ADs) published ten years after the benchmark 2014 study. Analyzing a massive dataset of 5.2 million CT exams from 2025, they break down the 22% reduction in national DRLs, explain why low dose isn't always good dose, and emphasize why clinical optimization and diagnostic image quality must take precedence over endless dose reduction.
Over the past decade, healthcare providers have worked relentlessly to lower radiation exposure in computed tomography (CT). But is continually dropping radiation doses always in the best interest of the patient?

In this episode of Rethink Imaging, host Chris St. John is joined by Dr. Kalpana Kanal, lead author on the original 2014 Diagnostic Reference Level (DRL) study and its 10-year follow-up, along with co-author Dr. Thomas Griglock. Together, they break down the findings from a modern dataset of 5.2 million CT exams, a substantial leap from the 1.3 million exams analyzed in 2014.

The guests detail how national DRLs dropped by 22% and achievable doses fell by 9%, signaling tighter protocol management across facilities nationwide. However, both experts caution against the public and media obsession with endless dose reduction. They explain why anatomy-specific constraints, such as the dense bone of the skull and the vital need for gray-white matter differentiation, place a natural floor on dose reduction for head CTs compared to body scans. Finally, they provide a practical roadmap for facilities using both modern optimization platforms and legacy equipment to benchmark their protocols responsibly without sacrificing diagnostic image quality.

What You'll Learn: 

Youtube Chapters: 


Rethink Imaging Podcast is handcrafted by our friends over at: fame.so